Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/2/25 21:03 | 6/30/25 | BCDA | Health | BioPrd | Biological Products, (No Diag | McClung David | CA | O | CFO | 2 | P.d | 35 | 1.95 | 0 | 18 | 60 | 48 | D | ||||||||||||||
7/2/25 21:02 | 6/30/25 | BCDA | Health | BioPrd | Biological Products, (No Diag | Altman Peter | CA | DO | P,CEO | 7 | P.dm | 107 | 1.99 | 0 | 54 | 48 | 166 | D | ||||||||||||||
7/2/25 21:02 | 6/30/25 | BCDA | Health | BioPrd | Biological Products, (No Diag | Stertzer Simon H | CA | D | 2 | P.d | 350 | 1.97 | 0 | 177 | 128 | 316 | I | |||||||||||||||
7/2/25 21:01 | 6/30/25 | BCDA | Health | BioPrd | Biological Products, (No Diag | Blank Andrew Scott | CA | D | 2 | P.d | 400 | 1.97 | 0 | 204 | 141 | 348 | I | |||||||||||||||
4/28/25 18:46 | 4/23/25 | BCDA | Health | BioPrd | Biological Products, (No Diag | Krasno Richard M | CA | D | 1 | P.d | 25 | 1.91 | 0 | 13 | 417 | 16 | D | |||||||||||||||
4/25/25 21:37 | 4/23/25 | BCDA | Health | BioPrd | Biological Products, (No Diag | Facteau Bill | CA | D | 1 | P.d | 25 | 1.91 | 0 | 13 | 13 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |